Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States.
J Clin Virol. 2013 Dec;58 Suppl 1(Suppl 1):e8-e12. doi: 10.1016/j.jcv.2013.09.002. Epub 2013 Sep 12.
Until recently most testing algorithms in the United States (US) utilized Western blot (WB) as the supplemental test. CDC has proposed an algorithm for HIV diagnosis which includes an initial screen with a Combo Antigen/Antibody 4th generation-immunoassay (IA), followed by an HIV-1/2 discriminatory IA of initially reactive-IA specimens. Discordant results in the proposed algorithm are resolved by nucleic acid-amplification testing (NAAT).
Evaluate the results obtained with the CDC proposed laboratory-based algorithm using specimens from men who have sex with men (MSM) obtained in five metropolitan statistical areas (MSAs).
Specimens from 992 MSM from five MSAs participating in the CDC's National HIV Behavioral Surveillance System in 2011 were tested at local facilities and CDC. The five MSAs utilized algorithms of various screening assays and specimen types, and WB as the supplemental test. At the CDC, serum/plasma specimens were screened with 4th generation-IA and the Multispot HIV-1/HIV-2 discriminatory assay was used as the supplemental test. NAAT was used to resolve discordant results and to further identify acute HIV infections from all screened-non-reactive missed by the proposed algorithm. Performance of the proposed algorithm was compared to site-specific WB-based algorithms.
The proposed algorithm detected 254 infections. The WB-based algorithms detected 19 fewer infections; 4 by oral fluid (OF) rapid testing and 15 by WB supplemental testing (12 OF and 3 blood). One acute infection was identified by NAAT from all screened-non-reactive specimens.
The proposed algorithm identified more infections than the WB-based algorithms in a high-risk MSM population. OF testing was associated with most of the discordant results between algorithms. HIV testing with the proposed algorithm can increase diagnosis of infected individuals, including early infections.
直到最近,美国(US)的大多数检测算法都利用 Western blot(WB)作为补充测试。CDC 提出了一种 HIV 诊断算法,包括使用 Combo 抗原/抗体四代免疫分析法(IA)进行初始筛查,然后对最初呈反应性的 IA 标本进行 HIV-1/2 鉴别性 IA。建议算法中的不一致结果通过核酸扩增检测(NAAT)解决。
评估使用来自五个大都市区(MSA)的男男性行为者(MSM)标本获得的 CDC 提出的基于实验室的算法的结果。
2011 年,五个参与 CDC 国家 HIV 行为监测系统的 MSA 的 992 名 MSM 的标本在当地机构和 CDC 进行了检测。这五个 MSA 使用了各种筛选检测和标本类型的算法,以及 WB 作为补充测试。在 CDC,血清/血浆标本用四代 IA 进行筛查,Multispot HIV-1/HIV-2 鉴别性检测作为补充测试。NAAT 用于解决不一致的结果,并进一步从所有筛查非反应性标本中识别急性 HIV 感染,这些感染被建议的算法漏掉了。将提出的算法的性能与特定于站点的基于 WB 的算法进行了比较。
该建议算法检测到 254 例感染。基于 WB 的算法检测到的感染少了 19 例;其中 4 例通过口腔液(OF)快速检测,15 例通过 WB 补充检测(12 例 OF 和 3 例血液)。通过所有筛查非反应性标本的 NAAT 鉴定出一例急性感染。
在高危 MSM 人群中,提出的算法比基于 WB 的算法检测到更多的感染。OF 检测与算法之间的大多数不一致结果有关。使用建议的算法进行 HIV 检测可以增加对感染者的诊断,包括早期感染。